🔎 Trials Near Me

Akèy › Kansè Endomèt › Illinois › Bloomington

Etid klinik pou Kansè Endomèt nan Bloomington, IL

4 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Bloomington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Ap rekriteFaz 3
  • Carle BroMenn Medical Center, Normal · 2 mi lwen
  • Carle Cancer Institute Normal, Normal · 2 mi lwen
Laj 18 ak plis · Fanm · Mizajou Sep 30, 2026 · NCT07198074

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Ap rekriteFaz 3
  • Carle Cancer Institute Normal, Normal · 2 mi lwen
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05256225

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Ap rekriteFaz 2
  • Illinois CancerCare-Bloomington, Bloomington
  • Carle BroMenn Medical Center, Normal · 2 mi lwen
  • Carle Cancer Institute Normal, Normal · 2 mi lwen
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT05564377

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Ap rekriteFaz 2
  • Carle BroMenn Medical Center, Normal · 2 mi lwen
  • Carle Cancer Institute Normal, Normal · 2 mi lwen
Laj 18 ak plis · Fanm · Mizajou Sep 28, 2026 · NCT05112601

Etid Kansè Endomèt nan lòt vil

Lòt etid nan Bloomington

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.